Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant in Japanese adults with chronic cough
NCT03482713Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefapixant in chronic cough, sponsored by Merck & Co.. Started Mar 2018; status: completed.
02
Drugs
gefapixant
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT03482713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482713.